Nutex Health (NUTX) Director Saunders Scott J Sells $43K of Stock
Key Points
- Nutex Health Inc. director Saunders Scott J sold 203 shares at $214.25 each on September 18, 2026.
- Institutional investors like Pertento Partners LLP and American Century Companies Inc adjusted their positions earlier in the year.
- Nutex Health operates a network of micro hospitals and specialty facilities across the United States.
Since the trade, $NUTX is up 5.4% after 1 week and down 10.9% to date (from the $208.79 close on Sep 18, 2026).
Get Nutex Health text alerts
We text you when insiders, Congress, analysts or big funds move on $NUTX.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Nutex Health Inc. alert may contain errors. Disclosures
Nutex Health Inc. director Saunders Scott J sold 203 shares of the healthcare company on September 18, 2026. According to a Form 4 filed with the Securities and Exchange Commission, the shares were sold at a price of $214.25 each, for a total transaction value of $43,492.75.
NUTX
Nutex Health Inc.
Inside Saunders Scott J's Nutex Health Trade
The transaction involved 203 shares sold on September 18, 2026, at $214.25 per share. On the day of the sale, Nutex Health shares closed at $208.79.
Other Institutional Activity in Nutex Health
Other large funds adjusted their stakes in Nutex Health during the period leading up to the filing. Pertento Partners LLP grew its holdings by 77,338 shares, ending with 451,310 shares worth about $83,988,793. American Century Companies Inc added 33,957 shares to hold 237,414 shares valued at about $44,182,746. Shaw D.E. & Co., Inc. increased its stake by 48,727 shares, finishing with 97,454 shares worth about $18,136,189. Winmill & Co. Inc kept its holding steady at 65,350 shares valued at about $12,161,635. Focus Partners Wealth opened a new position by adding 30,440 shares, ending with 60,881 shares worth about $11,329,954.
Nutex Health Inc. Stock Down 10.9%
The stock recently traded around $185.95 as of October 16, 2026, down about 10.9% since the September insider transaction when shares closed at $208.79.
Recent Earnings
Nutex Health reported trailing twelve-month revenue of $846,720,000 and earnings of $25.8 per share, alongside a net profit margin of 21.2% and return on equity of 64.6%. The next earnings report is scheduled for November 5, 2026.
Insider Buying and Selling at Nutex Health Inc.
Company insiders executed several trades prior to September. Officer Pamela W. Montgomery bought 79 shares on March 13, 2026, at $88.87 per share for a total of $7,021. Director Kelvin Spears picked up 10 shares on March 17, 2026, at $94.46 per share worth $945. President Warren Hosseinion acquired 252 shares on March 19, 2026, at $94.07 per share totaling $23,706. Director Frank E Jaumot bought 150 shares on March 20, 2026, at $93.56 per share for $14,033.
Analysts Set New Price Targets
Wall Street firms updated their views on the stock across several months. B. Riley Securities initiated coverage with a buy rating and a $290 price target on June 26, 2026. Lake Street maintained a buy rating while lifting its target from $235 to $310 on August 11, 2026. B. Riley Securities later reiterated its buy rating and raised its target to $325 on September 4, 2026. Freedom Capital Markets maintained a buy rating with a $306 target on September 25, 2026.
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services company that builds and runs micro hospitals, specialty hospitals, and outpatient departments across the United States. Its operations span hospital care, population health management, and real estate.
Bottom Line
Investors are keeping an eye on upcoming financial results scheduled for November 5, 2026. Regulatory filings will continue to provide updates on insider and institutional activity.
Related Filing Alerts
Source: Saunders Scott J's Form 4 filing on $NUTX (Sep 18, 2026). Written by software, not financial advice. How we make alerts